undamentalytics Newsletter

Meckler Jeffrey A: insider trades

Chief executive, Director at 3 companies we cover. 13 open-market purchases and no sales not made under a pre-set plan, reported from November 25, 2014 to November 22, 2022.

Would copying Meckler Jeffrey A’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 5 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on November 26, 2014 into $6,824 by November 2, 2026, −3.2% a year. The copy held shares only 27% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $14,457, +3.1% a year (the S&P 500 held throughout made $44,460, +13.4% a year). Beta against the index was 0.37. Twelve months after each report, the average purchase was +7.5% against the S&P 500 (median +5.9%), and 60% beat it. Measured from the trade date, the insider’s own timing, the average was +16.2%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 2014201620182020202220242026 $44.5k$14.5k$6.8k
Copying Meckler Jeffrey AS&P 500, same days investedS&P 500, held throughout $10,000 copying Meckler Jeffrey A’s open-market purchases from November 26, 2014, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−3.2%
S&P 500, same days invested
+3.1% (held throughout +13.4%)
Time in shares
27%
Sharpe ratio (S&P 500)
0.03 (0.68)
Biggest drop (S&P 500)
−86% (−34%)
Market sensitivity (beta)
0.37
Purchases copied
5

Trade by trade

Meckler Jeffrey A: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 5 +2.8% +13.2% 60% 3 — — Not enough years
Purchases, 6 months after the report 5 +23.4% −4.3% 40% 3 — — Not enough years
Purchases, 12 months after the report 5 +7.5% +5.9% 60% 3 — — Not enough years
Purchases, 12 months after the trade 5 +16.2% +21.0% 60% 3 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Indaptus Therapeutics, Inc. INDP CEO and Director60September 16, 2021November 22, 2022
Cocrystal Pharma, Inc. COCP CHIEF EXECUTIVE OFFICER40December 15, 2014March 17, 2016
Travere Therapeutics, Inc. TVTX —30November 25, 2014March 7, 2016

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 22, 2022November 18, 2022 INDP Purchase $18,944 not yetnot yetnot yet
September 12, 2022September 8, 2022 INDP Purchase $28,862 not yetnot yetnot yet
September 8, 2022September 6, 2022 INDP Purchase $24,771 not yetnot yetnot yet
June 7, 2022June 6, 2022 INDP Purchase $51,882 not yetnot yetnot yet
November 19, 2021November 18, 2021 INDP Purchase $65,108 −10.4%−53.0%−53.2%
September 16, 2021September 14, 2021 INDP Purchase $84,000 −46.2%−62.0%−53.3%
March 17, 2016March 15, 2016 COCP Purchase $150,000 not yetnot yetnot yet
March 7, 2016March 4, 2016 TVTX Purchase $76,550 +13.2%+5.9%+21.0%
March 3, 2016March 3, 2016 TVTX Purchase $144,500 +13.4%+21.0%+22.8%
December 28, 2015December 23, 2015 COCP Purchase $58,000 not yetnot yetnot yet
March 27, 2015March 25, 2015 COCP Purchase $150,000 not yetnot yetnot yet
December 15, 2014December 11, 2014 COCP Purchase $45,500 not yetnot yetnot yet
November 25, 2014November 25, 2014 TVTX Purchase $129,000 +43.7%+125.6%+143.8%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Meckler Jeffrey A traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.